Published in N Engl J Med on February 12, 1970
Suppression of in vitro Epstein-Barr virus infection. A new role for adult human T lymphocytes. J Exp Med (1977) 2.65
Studies on the diagnostic value of an immunofluorescence test for EB virus-specific IgM. J Clin Pathol (1974) 1.73
Infectious mononucleosis at the United States Military Academy. A prospective study of a single class over four years. Yale J Biol Med (1974) 1.61
Microbiome and malignancy. Cell Host Microbe (2011) 1.45
Burkitt's tumors contain particles encapsulating RNA-instructed DNA polymerase and high molecular weight virus-related RNA. Proc Natl Acad Sci U S A (1973) 1.44
Human lymphoblastoid cell lines and Epstein-Barr virus: a review of their interrelationships and their relevance to the etiology of leukoproliferative states in man. Yale J Biol Med (1971) 1.38
LMP1 strain variants: biological and molecular properties. J Virol (2006) 1.35
Potential selection of LMP1 variants in nasopharyngeal carcinoma. J Virol (2004) 1.34
RNA related to that of a murine leukemia virus in Burkitt's tumors and nasopharyngeal carcinomas. Proc Natl Acad Sci U S A (1973) 1.23
Serologic studies of acute respiratory infections in military personnel. Yale J Biol Med (1975) 1.17
X-Linked agammaglobulinemia patients are not infected with Epstein-Barr virus: implications for the biology of the virus. J Virol (1999) 1.15
Seroprevalence of Epstein-Barr virus infection in U.S. children ages 6-19, 2003-2010. PLoS One (2013) 1.11
Identification of a novel element involved in regulation of the lytic switch BZLF1 gene promoter of Epstein-Barr virus. J Virol (2001) 1.08
Epstein-Barr virus, infectious mononucleosis, and posttransplant lymphoproliferative disorders. Transplant Sci (1994) 1.06
Measurement of heterophil antibody and antibodies to EB viral capsid antigen IgG and IgM in suspected cases of infectious mononucleosis. J Clin Pathol (1976) 1.04
Natural history of primary Epstein-Barr virus infection in children of mothers infected with human immunodeficiency virus type 1. J Infect Dis (1999) 1.04
Environmental risk factors for multiple sclerosis: a review with a focus on molecular mechanisms. Int J Mol Sci (2012) 1.04
Immunological studies on Burkitt's lymphoma. Postgrad Med J (1971) 1.04
Core (2'-5')oligoadenylate and the cordycepin analog: inhibitors of Epstein--Barr virus-induced transformation of human lymphocytes in the absence of interferon. Proc Natl Acad Sci U S A (1981) 0.98
Return to play after infectious mononucleosis. Sports Health (2014) 0.96
ABO blood groups and viral diseases. Yale J Biol Med (1972) 0.93
Epstein-Barr virus infection in the neonatal period and in childhood. Can Med Assoc J (1974) 0.92
Herpesviruses. J Clin Pathol (1979) 0.89
Unique nuclear DNA sequences in the involved tissues of Hodgkin's and Burkitt's lymphomas. Proc Natl Acad Sci U S A (1973) 0.89
Clinical and virologic manifestations of primary Epstein-Barr virus (EBV) infection in Kenyan infants born to HIV-infected women. J Infect Dis (2013) 0.87
Recovery from infectious mononucleosis: a case for more than symptomatic therapy? A systematic review. Br J Gen Pract (2002) 0.87
Primary CD4+ T-cell responses provide both helper and cytotoxic functions during Epstein-Barr virus infection and transformation of fetal cord blood B cells. J Virol (2007) 0.86
Epstein-Barr virus antibody in cases and contacts of infectious mononucleosis; a family study. J Hyg (Lond) (1973) 0.84
Epidemiological studies of Epstein-Barr herpesvirus infection in Western Australia. J Hyg (Lond) (1975) 0.83
The EB virus in relation to infectious mononucleosis. J Clin Pathol Suppl (R Coll Pathol) (1972) 0.82
Infectious mononucleosis: observations on transmission. Yale J Biol Med (1983) 0.82
Effects of dialyzable transfer factor in patients with breast cancer. Proc Natl Acad Sci U S A (1974) 0.82
Relationship of in vitro immune responses to Epstein-Barr herpesvirus and severity of infectious mononucleosis. Infect Immun (1980) 0.81
Use of staged molecular analysis to determine causes of unexplained central nervous system infections. Emerg Infect Dis (2013) 0.80
Aspects of Epstein-Barr virus infection in childhood. Arch Dis Child (1974) 0.80
EB virus antibody and infectious mononucleosis in a boarding school for boys. J Clin Pathol (1976) 0.80
Incidence, risk factors and outcomes of de novo malignancies post liver transplantation. World J Hepatol (2016) 0.78
Incidence of Infectious Mononucleosis in Universities and U.S. Military Settings. J Diagn Tech Biomed Anal (2014) 0.78
Chronic fatigue syndrome. A critical appraisal of the role of Epstein-Barr virus. West J Med (1989) 0.77
Influence of CMV/EBV serostatus on respiratory infection incidence during 4 months of winter training in a student cohort of endurance athletes. Eur J Appl Physiol (2013) 0.77
Infectious mononucleosis and its relationship to EB virus antibody. A joint investigation by university health physicians and P.H.L.S. laboratories. Br Med J (1971) 0.77
Analysis of the tumorigenic potential of common marmoset lymphoblastoid cells expressing a constitutively activated c-myc gene. Br J Cancer (1993) 0.76
Commentary. EB virus, infectious mononucleosis, and cancer: the closing of the web. Yale J Biol Med (1974) 0.75
Success and failure in human virus diseases. II. Common viruses. Br Med J (1971) 0.75
Epstein-Barr virus-carrying B cells are large, surface IgM, IgD-bearing cells in normal individuals and acute malaria patients. Immunology (1994) 0.75
Myths about infectious mononucleosis. Can Med Assoc J (1983) 0.75
Laboratory diagnosis of EB virus infection in some cases presenting as hepatitis. J Clin Pathol (1978) 0.75
Acute respiraotry diseases in students at the University of the Philippines, 1964-69. Bull World Health Organ (1971) 0.75
BLT-esterase in infectious mononucleosis. Clin Exp Immunol (1995) 0.75
Heterophile binding of human antibodies to glycoproteins of retroviruses. Br J Cancer (1981) 0.75
The incidence of epstein-barr virus primary infection among suspected patients referred to namazi hospital of shiraz, iran. Jundishapur J Microbiol (2015) 0.75
Role of immunologic disturbance in human oncogenesis: some facts and fancies. Br J Cancer (1971) 0.75
Antibodies against tumours. Br Med J (1971) 0.75
Causation and disease: the Henle-Koch postulates revisited. Yale J Biol Med (1976) 4.83
Infectious mononucleosis. Clinical manifestations in relation to EB virus antibodies. JAMA (1968) 4.26
Relation of Australia-SH antigen to the willowbrook MS-2 strain. N Engl J Med (1969) 4.13
Prolonged oropharyngeal excretion of Epstein-Barr virus after infectious mononucleosis. N Engl J Med (1973) 3.33
Seroepidemiologic studies of infectious mononucleosis with EB virus. N Engl J Med (1968) 3.12
Australia antigen in acute and chronic liver disease. Lancet (1969) 2.65
A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer. Lancet (1996) 2.59
Distribution of microtubule organizing centers in migrating sheets of endothelial cells. J Cell Biol (1981) 2.51
A prospective evaluation of heterophile and Epstein-Barr virus-specific IgM antibody tests in clinical and subclinical infectious mononucleosis: Specificity and sensitivity of the tests and persistence of antibody. J Infect Dis (1975) 2.24
Localization of the neurofilament protein in neuroblastoma cells by immunofluorescent staining. Proc Natl Acad Sci U S A (1976) 2.17
Viral infections in renal transplant recipients. Infect Immun (1976) 2.03
Uterine rupture in midtrimester abortion. A complication of gemeprost vaginal pessaries and oxytocin. Case report. Br J Obstet Gynaecol (1990) 2.02
Streptococcal infections: observations from a public health laboratory. Am J Public Health Nations Health (1965) 1.89
Prospective studies of a group of Yale University freshmen. I. Occurrence of infectious mononucleosis. J Infect Dis (1971) 1.85
Depression of cell-mediated immunity during acute infectious mononucleosis. N Engl J Med (1974) 1.74
Infectious mononucleosis at the United States Military Academy. A prospective study of a single class over four years. Yale J Biol Med (1974) 1.61
Raised antibody titres to E.B. virus in systemic lupus erythematosus. Lancet (1971) 1.60
Evidence for persistence of infectious agents in isolated human populations. Am J Epidemiol (1974) 1.54
Antibodies to early antigens induced by Epstein-Barr virus in infectious mononucleosis. J Infect Dis (1971) 1.48
Expression of Epstein-Barr viral early antigen in monolayer tissue cultures after transfection with viral DNA and DNA fragments. J Virol (1981) 1.48
The spectrum of infections with Epstein-Barr virus: a hypothesis. J Infect Dis (1971) 1.44
Detection of virus-specific antigens in EB-(P3HR1) virus-superinfected Raji cells by immunoprecipitation. Virology (1980) 1.43
Characterization of differentially expressed genes in purified Drosophila follicle cells: toward a general strategy for cell type-specific developmental analysis. Proc Natl Acad Sci U S A (1999) 1.39
Microtubule-organizing centers and cell migration: effect of inhibition of migration and microtubule disruption in endothelial cells. J Cell Biol (1983) 1.36
Site of Epstein-Barr virus replication in the oropharynx. Lancet (1979) 1.34
Cervical intraepithelial neoplasia and 'wary' atypia: a study of colposcopic, histological and cytological characteristics. Br J Obstet Gynaecol (1982) 1.31
Causation and disease: a chronological journey. The Thomas Parran Lecture. Am J Epidemiol (1978) 1.31
Infiltration of cervical cancer tissue with human papillomavirus-specific cytotoxic T-lymphocytes. Cancer Res (1997) 1.29
maelstrom is required for an early step in the establishment of Drosophila oocyte polarity: posterior localization of grk mRNA. Development (1997) 1.28
EBV-IgA and new heterophile antibody tests in diagnosis of infectious mononucleosis. Am J Clin Pathol (1982) 1.27
Infectious mononucleosis. Epstein-Barr-virus shedding in saliva and the oropharynx. N Engl J Med (1976) 1.26
Cytomegalovirus macroglobulin in cell-associated herpesvirus infections. J Infect Dis (1972) 1.25
Serum amyloid A changes high density lipoprotein's cellular affinity. A clue to serum amyloid A's principal function. Lab Invest (1992) 1.22
Australia (hepatitis-associated) antigen: physicochemical and immunological characteristics. Adv Virus Res (1970) 1.21
A population-based case-control study of EBV and other viral antibodies among persons with Hodgkin's disease and their siblings. Int J Cancer (1984) 1.21
Transposon insertions causing constitutive Sex-lethal activity in Drosophila melanogaster affect Sxl sex-specific transcript splicing. Genetics (1995) 1.20
Antibody to the rheumatoid arthritis nuclear antigen. Its relationship to in vivo Epstein-Barr virus infection. J Clin Invest (1980) 1.19
Clinical and laboratory aspects of raised virus antibody titres in systemic lupus erythematosus. Ann Rheum Dis (1973) 1.19
Infectious mononucleosis: appearance of neutralizing antibody to Epstein-Barr virus measured by inhibition of formation of lymphoblastoid cell lines. J Infect Dis (1972) 1.19
Serologic studies of acute respiratory infections in military personnel. Yale J Biol Med (1975) 1.17
Antibody responses to two Epstein-Barr virus nuclear antigens defined by gene transfer. N Engl J Med (1985) 1.14
Infectious mononucleosis and other mono-like syndromes. N Engl J Med (1972) 1.13
Antigen processing defects in cervical carcinomas limit the presentation of a CTL epitope from human papillomavirus 16 E6. J Immunol (2001) 1.13
Pettenkofer revisited: the life and contributions of Max von Pettenkofer (1818-1901). Yale J Biol Med (1973) 1.11
Viral hepatitis: report on WHO informal consultation. J Med Virol (1981) 1.10
Antisera against electrophoretically purified tubulin stimulate colchicine-binding activity. Proc Natl Acad Sci U S A (1976) 1.07
Prospective studies of a group of Yale University freshmen. II. Occurrence of acute respiratory infections and rubella. J Infect Dis (1971) 1.07
Delayed hypersensitivity in hepatitis B: clinical correlates of in vitro production of migration inhibition factor. J Infect Dis (1974) 1.06
Thermostable Clostridium perfringens as cause of food poisoning outbreak. Public Health Rep (1967) 1.06
Infectious mononucleosis--role of EB virus. N Engl J Med (1969) 1.05
A randomized, double blind controlled trial of the efficacy of immune serum globulin for the prevention of post-transfusion hepatitis. A Veterans Administration cooperative study. Gastroenterology (1977) 1.04
A nationwide serum survey of Argentinian military recruits, 1965-1966. I. Description of sample and antibody patterns with arboviruses, polioviruses, respiratory viruses, tetanus and treponematosis. Am J Epidemiol (1971) 1.04
The eradication of communicable diseases: myth or reality? Am J Epidemiol (1985) 1.04
Clinical syndromes in adults caused by respiratory infection. Med Clin North Am (1967) 1.03
Epidemiology of infections with rhinovirus types 43 and 55 in a group of university of Wisconsin student families. Am J Epidemiol (1967) 1.03
The risk of acute respiratory infections in two groups of young adults in Colombia, South America. A prospective seroepidemiologic study. Am J Epidemiol (1971) 1.02
Infectious mononucleosis and related syndromes. Am J Med Sci (1979) 1.01
Psychosocial risk factors in the developmental of infectious mononucleosis. Psychosom Med (1979) 1.01
A seroepidemiological study of Epstein-Barr virus and other viral antigens in sarcoidosis. Am J Epidemiol (1973) 1.00
Spontaneous resolution of cervical warty atypia: the relevance of clinical and nuclear DNA features: a prospective study. Br J Obstet Gynaecol (1985) 0.99
Fragment length polymorphisms among independent isolates of Epstein-Barr virus from immunocompromised and normal hosts. J Infect Dis (1988) 0.99
Serum antigens in viral hepatitis. J Infect Dis (1969) 0.98
A nationwide serum survey of Colombian military recruits, 1966. I. Description of sample and antibody patterns with arboviruses, polioviruses, respiratory viruses tetanus, and treponematosis. Am J Epidemiol (1969) 0.96
The history of infectious mononucleosis. Am J Med Sci (1974) 0.96
The role of clinical follow up in early stage cervical cancer in South Wales. BJOG (2004) 0.96
Clinical studies of human papilloma vaccines in pre-invasive and invasive cancer. Vaccine (2001) 0.95
A community outbreak of Mycoplasma pneumonia. JAMA (1968) 0.94
Subtypes of Australia antigen and hepatitis-B virus. JAMA (1972) 0.94
ABO blood groups and viral diseases. Yale J Biol Med (1972) 0.93
The need for serologic evaluation of immunization programs. Am J Epidemiol (1980) 0.91
Enzyme-linked immunosorbent assay of antibodies to Epstein-Barr virus nuclear and early antigens in patients with infectious mononucleosis and nasopharyngeal carcinoma. Ann Intern Med (1986) 0.91
Limitation of Koch's postulates. Lancet (1977) 0.90
Nonhuman primate-associated viral hepatitis type A. Serologic evidence of hepatitis A virus infection. JAMA (1976) 0.90
Mycoplasma pneumoniae infections in University of Wisconsin students. Am Rev Respir Dis (1967) 0.89
Hepatitis-B antigen in Iran: frequency and subtype. Lancet (1972) 0.89
Presence of elevated antibody titres to Epstein-Barr virus before Hodgkin's disease. Lancet (1981) 0.89
Kinetics of the antibody response to BamHI-K nuclear antigen in uncomplicated infectious mononucleosis. J Infect Dis (1986) 0.89
Astrocyte cell lineage. II. Mouse fibrous astrocytes and reactive astrocytes in cultures have vimentin- and GFP-containing intermediate filaments. Brain Res (1983) 0.88
Localization of tropomyosin in mouse embryo fibroblasts. Am J Anat (1975) 0.88
Hypothesis: the pathogenesis of AIDS. Activation of the T- and B-cell cascades. Yale J Biol Med (1984) 0.88
Prevalence of antibody against viruses in the Tiriyo, an isolated Amazon tribe. Am J Epidemiol (1970) 0.88
Radiofrequency coblation for treatment of advanced laryngotracheal recurrent respiratory papillomatosis. J Laryngol Otol (2009) 0.88